insights_auto
Why is ORX down 6.27%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 0.82
arrow_downward
-6.27%(-0.055) 1D
ኖቬም 16, 9:34:28 ጥዋት ጂ ኤም ቲ+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
287.76 ሚ
Avg. vol.
777.72 ሺ
Volume
145.37 ሺ
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13 ሚ
No. of employees
55
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
287.76 ሚ
Avg. vol.
777.72 ሺ
Volume
145.37 ሺ
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13 ሚ
No. of employees
55
News stories
From web sources and news partners
Investing.com
·
ከ1 ሰዓት በፊት
Bulls See S&P 500 Hitting 7,900 by Year-End as Earnings and Valuations Improve
Yahoo Finance
·
ከ52 ደቂቃዎች በፊት
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
TradingView
·
ከ2 ሰዓቶች በፊት
Stock Market: Will S&P 500 Open Up or Down Today?
StoneX
·
ከ3 ቀናት በፊት
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com